Navigation Links
Pharmacyclics Reports Second Quarter 2013 Results
Date:7/31/2013

th R/R CLL/SLL. This trial is a randomized, multi-center, open-label Phase III trial of ibrutinib as a monotherapy. The enrollment of 391 patients was completed more than two quarters ahead of schedule in April, 2013. The primary endpoint of this study is to demonstrate a clinically significant improvement in progression-free survival (PFS) when compared to ofatumumab. A pre-defined number of progression events will trigger an interim analysis. Pharmacyclics expects a read out from the interim analysis during Q1 of 2014. If the treatment effect of ibrutinib in comparison to ofatumumab is deemed statistically favorable by an independent review committee, a discussion with the FDA and other health authorities for a potential early filing may take place.
  • RESONATE™-17 (PCYC-1117): Phase II study of ibrutinib in a single-arm, open-label, multi-center trial using ibrutinib as a monotherapy in patients who have deletion 17p and who did not respond to or relapsed after at least one prior treatment (a high unmet need population). The primary endpoint of the study is the overall response rate (ORR). This global study has just completed enrollment more than two quarters ahead of schedule. Pharmacyclics plans to announce top-line data from this study in the first half of 2014.
  • RESONATE™-2 (PCYC-1115): Phase III study of ibrutinib versus chlorambucil in frontline newly diagnosed elderly CLL/SLL patients. This trial is a randomized, multicenter, open-label study of ibrutinib as a monotherapy versus chlorambucil in patients 65 years or older with treatment naive CLL/SLL. The study design, which was granted a Special Protocol Assessment (SPA), is designed to demonstrate superiority of ibrutinib with the primary endpoint of PFS when compared to chlorambucil. The study is currently recruiting and Pharmacyclics plans to enroll 272 patients worldwide, with an enrollment completion target by the end of Q3 of 2014.
  • HELIOS (CLL3001): Phase II
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
    2. Pharmacyclics Reports First Quarter 2013 Results
    3. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    4. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    5. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    6. Pharmacyclics, Inc. Prices Public Offering of Common Stock
    7. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
    8. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
    9. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
    10. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
    11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/26/2015)... , March 26, 2015 Huntington Memorial Hospital ... to perform transcatheter aortic valve replacement (TAVR), a minimally ... a revolutionary new way to replace an aortic valve ... heart lung machine. The procedure is performed ... by Azhil ( Alex) Durairaj , MD, interventional cardiologist ...
    (Date:3/26/2015)... Mich. , March 26, 2015 Cardiologists ... have performed the Midwest,s first commercial implant of a ... for patients with non-valvular atrial fibrillation. The Watchman Left ... use of blood-thinning warfarin medication to reduce the risk ... common heart rhythm disorder affecting more than 5 million ...
    (Date:3/26/2015)... YORK , March 26, 2015 ... the average American consumer. However, a new survey ... various ailments from the common cold to diabetes, ... The research, conducted by the Private Label ... on over-the-counter healthcare products, including those essential for ...
    Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3Consumers can keep over-the-counter medicine affordable by using store brands 2
    ... 11 Percent Fewer RA Patients,Reported Job Loss ... Methotrexate Alone, BARCELONA, Spain, June 15, 2007 ... the most common causes of,disability in the ... that,rheumatoid arthritis (RA) patients treated with Abbott's ...
    ... WYCOMBE, England, June 18, 2007 /PRNewswire/ -- Previously,undisclosed ... has the,potential to protect against all strains of ... PepTcell, at the 2007,Options for the Control of ... pre-clinical results, which will be published in the,European ...
    Cached Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
    (Date:3/26/2015)... March 26, 2015 Florida Hospital teamed up ... For Your Health campaign and live Dr. Oz event, which ... March 21st. More than a thousand people came out to ... living. , The world renowned cardiothoracic surgeon and Emmy ... Linda Hurtado and a panel of experts for the live ...
    (Date:3/26/2015)... Building off their success and reputation ... Cardiometabolic Risk Summit and Goldring ... are proud to announce a pioneering professional certification ... program , which ultimately grants a Certified Culinary ... nurse practitioners, physician assistants, registered dietitians, and pharmacists ...
    (Date:3/26/2015)... CO (PRWEB) March 26, 2015 Saving ... help where it is most needed but least available. ... therapeutic milk to six clinics in the Benguela province ... severe malnutrition. During a recent visit to their clinics, ... to the mothers and their babies in a nation ...
    (Date:3/26/2015)... (PRWEB) March 26, 2015 Pacific Medical ... is pleased to be featured on Innovations with Ed ... March 18, 2015. The episode will repeat on ... live on the Pacific Medical home page at: ... threatening emergencies, it is reassuring to trust the integrity ...
    (Date:3/26/2015)... DC (PRWEB) March 26, 2015 ... Center for Assessment and Evaluation , has announced ... that enable institutions, organizations, and corporations to accurately ... promote successful learning. , Utilizing Questionmark’s state-of-the-art ... Services will offer improved delivery of the ...
    Breaking Medicine News(10 mins):Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2
    ... thought to develop these infections, , , TUESDAY, March 24 ... antibacterial agent to the dressing around the spot where ... chances that a potentially deadly infection will develop, French ... usually require insertion of a central venous catheter. In ...
    ... virus type 16 (HPV16) and HPV type 18 (HPV18) were ... Mexico in the 1980s and 1990s, according to a population-based ... Journal of the National Cancer Institute. , ... cancer was 5 years younger than that of women diagnosed ...
    ... Tissue Culture Cells ,Infection with human ... transcriptase (hTERT) gene in both normal human cells ... has been suspected of causing or promoting cancer, ... has been unclear. Several other cancer-related viruses stimulate ...
    ... March 24 Offering innovative health plans that emphasize wellness ... has produced healthy enrollment growth for MVP Health Care. ... with 700,000 members at the same time in 2008. ... enrollment. "We experienced growth in all of our products ...
    ... EMH Swiss Medical Publisher Ltd. (Schweizerische Arzteverlag AG) ... agreement to deploy Aries, Editorial Manager online peer-review system ... with deployment of Editorial Manager to two of the ... and Kardiovaskulare Medizin. First published in 1871 ...
    ... Md., March 24 AMIA is pleased to ... School of Nursing (UMN) in the AMIA 10x10 program. ... Center for Nursing Minimum Data Set Knowledge Discovery, will serve ... School of Nursing 10x10 offering. "The University of Minnesota ...
    Cached Medicine News:Health News:Drug-Coated Sponges May Limit Catheter Infections 2Health News:Human papillomavirus genotype distribution in New Mexico cervical cancers 2Health News:Also in the March 24 JNCI 2Health News:Also in the March 24 JNCI 3Health News:Also in the March 24 JNCI 4Health News:Also in the March 24 JNCI 5Health News:Also in the March 24 JNCI 6Health News:MVP Health Care Reports Enrollment Growth 2Health News:MVP Health Care Reports Enrollment Growth 3Health News:EMH Swiss Medical Publisher Ltd. Selects Editorial Manager for Online Peer Review 2Health News:New AMIA 10x10 Program Partner -- University of Minnesota School of Nursing 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: